サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1605808

医薬品・医療機器組合せ製品市場、規模、シェア、動向、産業分析レポート：製品タイプ別、用途別、エンドユーザー別、地域別 - 市場予測、2025年～2034年

Drug Device Combination Products Market Size, Share, Trends, Industry Analysis Report, By Type, Application, End user, and Region- Market Forecast, 2025 - 2034

出版日
ページ情報
英文 118 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
医薬品・医療機器組合せ製品市場、規模、シェア、動向、産業分析レポート：製品タイプ別、用途別、エンドユーザー別、地域別 - 市場予測、2025年～2034年
出版日: 2024年11月01日
発行: Polaris Market Research
ページ情報: 英文 118 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、世界の医薬品・医療機器組合せ製品の市場規模は2034年までに3,435億9,000万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

世界中で高齢者人口が増加していることが、世界の医薬品・医療機器組合せ製品市場を牽引しています。高齢者は一般的に、糖尿病、高血圧、関節炎などいくつかの慢性疾患を抱えています。ドラッグデリバリーとモニタリングやその他のサポート機能を組み合わせた医薬品・医療機器組合せ製品は、こうした複雑な健康要件に対応する上で特に有利であるため、ニーズが高まっています。このように、高齢者人口の増加が市場を拡大しています。

国連が発表した報告書によると、世界の65歳以上の高齢者数は2倍以上に増加し、2021年の7億6,100万人から2050年には16億人になると予測されています。

医薬品・医療機器組合せ製品の世界市場は、糖尿病の罹患率の上昇によって活性化しています。糖尿病の管理には、継続的な投薬とモニタリングが必要です。インスリンポンプや持続グルコースモニター（CGM）のような医薬品・医療機器組合せ製品は、ドラッグデリバリーとモニタリングを1つのデバイスに統合することで糖尿病管理を合理化し、患者の利便性を高めることで需要を押し上げています。

ドラッグデリバリー活動への投資の高まりが、世界の医薬品・医療機器組合せ製品市場を後押ししています。同市場の企業は、特定の医療ニーズに対応する製品を開発し、投資を増やすことで現行のソリューションよりも優れた性能を実現できます。このため、より高度で最新のドラッグデリバリー機器に対するニーズが高まっています。

医薬品・医療機器組合せ製品市場レポートハイライト

経皮パッチセグメントは、低侵襲で患者に優しいドラッグデリバリーソリューションに対する需要の高まりと一致する非侵襲性により、2024年の市場シェアを独占しました。

薬剤溶出ステント分野は、動脈の再狭窄を防ぐ薬剤を放出することで冠動脈疾患の治療に有効であることから、調査期間中に最も高い成長が見込まれています。

冠動脈疾患や心不全を管理するための高度な技術に対する切実なニーズにより、2024年には心血管疾患分野が最大の市場シェアを占めました。

高度なヘルスケアインフラ、高レベルの研究開発活動、技術革新と市場参入を支援する強力な規制枠組みにより、2024年の市場は北米が支配的でした。さらに、多数の主要製薬企業や医療機器企業が存在することも、このセグメントの優位性に寄与しています。

アジア太平洋地域は、ヘルスケアセクターの拡大、医療技術への投資の増加、患者数の増加を背景に、調査期間中に最も速い成長を記録すると予測されています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の医薬品・医療機器組合せ製品市場の洞察

  • 市場スナップショット
  • 医薬品・医療機器組合せ製品市場の力学
    • 促進要因と機会
      • 糖尿病の罹患率の増加が市場を牽引
      • 世界中での高齢者人口の増加による市場の拡大
    • 抑制要因と課題
      • 複雑な規制環境が医薬品・医療機器組合せ製品市場の成長を抑制
  • PESTEL分析
  • 医薬品・医療機器組合せ製品市場動向
  • バリューチェーン分析
  • COVID-19の影響分析

第5章 世界の医薬品・医療機器組合せ製品市場：タイプ別

  • 主な調査結果
  • イントロダクション
  • 薬剤溶出ステント
  • 輸液ポンプ
  • 吸入器
  • 整形外科用複合製品
  • 創傷ケア複合製品
  • 光線力学療法装置
  • 経皮パッチ
  • 抗菌カテーテル
  • その他

第6章 世界の医薬品・医療機器組合せ製品市場：用途別

  • 主な調査結果
  • イントロダクション
  • 心血管疾患
  • 糖尿病
  • 呼吸器系の問題
  • がん治療
  • その他

第7章 世界の医薬品・医療機器組合せ製品市場：エンドユーザー別

  • 主な調査結果
  • イントロダクション
  • 病院
  • 外来手術センター
  • その他

第8章 世界の医薬品・医療機器組合せ製品市場：地域別

  • 主な調査結果
  • イントロダクション
    • 医薬品・医療機器組合せ製品市場評価：地域別、2020年～2034年
  • 北米
    • 北米：タイプ別、2020年～2034年
    • 北米：用途別、2020年～2034年
    • 北米：エンドユーザー別、2020年～2034年
    • 米国
    • カナダ
  • 欧州
    • 欧州：タイプ別、2020-2034
    • 欧州：用途別、2020年～2034年
    • 欧州：エンドユーザー別、2020年～2034年
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • スペイン
    • オランダ
    • ロシア
    • その他欧州
  • アジア太平洋
    • アジア太平洋：タイプ別、2020年～2034年
    • アジア太平洋：用途別、2020年～2034年
    • アジア太平洋：エンドユーザー別、2020年～2034年
    • 中国
    • インド
    • マレーシア
    • 日本
    • インドネシア
    • 韓国
    • オーストラリア
    • その他アジア太平洋
  • 中東・アフリカ
    • 中東・アフリカ：タイプ別、2020年～2034年
    • 中東・アフリカ：用途別、2020年～2034年
    • 中東・アフリカ：エンドユーザー別、2020年～2034年
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東・アフリカ
  • ラテンアメリカ
    • ラテンアメリカ：タイプ別、2020年～2034年
    • ラテンアメリカ：用途別、2020年～2034年
    • ラテンアメリカ：エンドユーザー別、2020年～2034年
    • メキシコ
    • ブラジル
    • アルゼンチン
    • その他ラテンアメリカ

第9章 競合情勢

  • 拡大と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第10章 企業プロファイル

  • Abbott
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Medtronic
  • Novartis AG
  • Sensely, Inc.
  • Stryker
  • Teleflex Incorporated
  • Terumo Medical Corporation
  • Viatris Inc.
  • Hovione
図表

List of Tables:

  • Table 1 Global Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 2 Global Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 3 Global Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 4 North America: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 5 North America: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 6 North America: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 7 U.S.: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 8 U.S.: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 9 U.S.: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 10 Canada: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 11 Canada: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 12 Canada: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 13 Europe: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 14 Europe: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 15 Europe: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 16 UK: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 17 UK: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 18 UK: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 19 France: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 20 France: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 21 France: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 22 Germany: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 23 Germany: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 24 Germany: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 25 Italy: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 26 Italy: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 27 Italy: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 28 Spain: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 29 Spain: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 30 Spain: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 31 Netherlands: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 32 Netherlands: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 33 Netherlands: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 34 Russia: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 35 Russia: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 36 Russia: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 37 Rest of Europe: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 38 Rest of Europe: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 39 Rest of Europe: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 40 Asia Pacific: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 41 Asia Pacific: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 42 Asia Pacific: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 43 China: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 44 China: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 45 China: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 46 India: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 47 India: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 48 India: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 49 Malaysia: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 50 Malaysia: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 51 Malaysia: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 52 Japan: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 53 Japan: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 54 Japan: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 55 Indonesia: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 56 Indonesia: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 57 Indonesia: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 58 South Korea: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 59 South Korea: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 60 South Korea: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 61 Australia: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 62 Australia: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 63 Australia: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 64 Rest of Asia Pacific: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 65 Rest of Asia Pacific: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 66 Rest of Asia Pacific: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 67 Middle East & Africa: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 68 Middle East & Africa: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 69 Middle East & Africa: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 70 Saudi Arabia: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 71 Saudi Arabia: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 72 Saudi Arabia: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 73 UAE: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 74 UAE: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 75 UAE: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 76 Israel: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 77 Israel: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 78 Israel: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 79 South Africa: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 80 South Africa: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 81 South Africa: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 82 Rest of Middle East & Africa: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 83 Rest of Middle East & Africa: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 84 Rest of Middle East & Africa: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 85 Latin America: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 86 Latin America: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 87 Latin America: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 88 Mexico: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 89 Mexico: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 90 Mexico: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 91 Brazil: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 92 Brazil: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 93 Brazil: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 94 Argentina: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 95 Argentina: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 96 Argentina: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 97 Rest of Latin America: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 98 Rest of Latin America: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 99 Rest of Latin America: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • List of Figures:
  • Figure 1. Global Drug Device Combination Products Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Type
  • Figure 7. Global Drug Device Combination Products Market, by Type, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Application
  • Figure 9. Global Drug Device Combination Products Market, by Application, 2024 & 2034 (USD Billion)
  • Figure 10. Market by End-user
  • Figure 11. Global Drug Device Combination Products Market, by End-user, 2024 & 2034 (USD Billion)
目次
Product Code: PM5167

The global drug device combination products market size is expected to reach USD 343.59 billion by 2034, according to a new study by Polaris Market Research. The report "Drug Device Combination Products Market Size, Share, Trends, Industry Analysis Report, By Type (Drug Eluting Stents, Infusion Pumps, Inhalers, Orthopedic Combination Products, Wound Care Combination Products, Photodynamic Therapy Devices, Transdermal Patches, Antimicrobial Catheters, and Others), Application, End user, and Region-Market Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The rising geriatric population across the globe is driving the global drug device combination products market. Elderly individuals commonly have several chronic ailments like diabetes, hypertension, and arthritis. Drug-device combination products that combine medication delivery with monitoring or other supportive functions are especially advantageous for addressing these intricate health requirements, thus increasing the need. Thus, the growing geriatric population is expanding the market. For instance,

According to a report published by the United Nations, the number of people aged 65 years or older worldwide is projected to more than double, rising from 761 million in 2021 to 1.6 billion in 2050.

The global market for drug-device combination products is being fueled by the rising incidence of diabetes. Managing diabetes involves continuous medication and monitoring. Drug-device combination products, like insulin pumps or continuous glucose monitors (CGMs), streamline diabetes management by integrating drug delivery and monitoring into one device, increasing convenience for the patient and thereby boosting demand.

The rising investments in drug delivery activities are propelling the global drug device combination products market. Companies in the market are able to create products that cater to specific medical needs and deliver better performance than current solutions with increased investment. This drives the need for more advanced and up-to-date drug delivery devices.

Drug Device Combination Products Market Report Highlights

The transdermal patches segment dominated the market share in 2024 due to their non-invasive nature, which aligns with the rising demand for minimally invasive and patient-friendly drug delivery solutions.

Drug eluting stents segment is anticipated to witness the highest growth over the study period, due to their effectiveness in treating coronary artery disease by releasing medications that prevent restenosis of the artery.

Cardiovascular disorders segment accounted for the largest market share in 2024, owing to the critical need for advanced technologies for managing coronary artery disease and heart failure.

North America dominated the market in 2024 due to the advanced healthcare infrastructure, high levels of research and development activity, and strong regulatory frameworks that support innovation and market entry. Additionally, the presence of numerous leading pharmaceutical and medical device companies contributed to the segment's dominance.

Asia Pacific is projected to register the fastest growth over the study period, attributable to the expanding healthcare sector, increasing investments in medical technology, and rising patient populations.

The global players include Abbott; Becton, Dickinson and Company; Boston Scientific Corporation; Medtronic; Novartis AG; Sensely, Inc.; Stryker; Teleflex Incorporated; Terumo Medical Corporation; Viatris Inc.; and Hovione.

Polaris Market Research has segmented the drug device combination products market report based on type, application, End user, and region.

By Type Outlook (Revenue - USD Billion, 2020 - 2034)

  • Drug Eluting Stents
  • Infusion Pumps
  • Inhalers
  • Orthopedic Combination Products
  • Wound Care Combination Products
  • Photodynamic Therapy Devices
  • Transdermal Patches
  • Antimicrobial Catheters
  • Others

By Application Outlook (Revenue - USD Billion, 2020 - 2034)

  • Cardiovascular Disorder
  • Diabetes
  • Respiratory Problems
  • Cancer Treatment
  • Others

By End user Outlook (Revenue - USD Billion, 2020 - 2034)

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

By Regional Outlook (Revenue - USD Billion, 2020 - 2034)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Australia
  • Rest of Asia Pacific
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Drug Device Combination Products Market Insights

  • 4.1. Drug Device Combination Products Market - Market Snapshot
  • 4.2. Drug Device Combination Products Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing prevalence of diabetes is driving the market.
      • 4.2.1.2. Growing geriatric population worldwide propels the market.
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Complex regulatory environment is hindering the drug device combination products market growth
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Drug Device Combination Products Market Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Drug Device Combination Products Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • 5.3. Drug Eluting Stents
    • 5.3.1. Global Drug Device Combination Products Market, by Drug Eluting Stents, by Region, 2020-2034 (USD Billion)
  • 5.4. Infusion Pumps
    • 5.4.1. Global Drug Device Combination Products Market, by Infusion Pumps, by Region, 2020-2034 (USD Billion)
  • 5.5. Inhalers
    • 5.5.1. Global Drug Device Combination Products Market, by Inhalers, by Region, 2020-2034 (USD Billion)
  • 5.6. Orthopedic Combination Products
    • 5.6.1. Global Drug Device Combination Products Market, by Orthopedic Combination Products, by Region, 2020-2034 (USD Billion)
  • 5.7. Wound Care Combination Products
    • 5.7.1. Global Drug Device Combination Products Market, by Wound Care Combination Products, by Region, 2020-2034 (USD Billion)
  • 5.8. Photodynamic Therapy Device
    • 5.8.1. Global Drug Device Combination Products Market, by Photodynamic Therapy Device, by Region, 2020-2034 (USD Billion)
  • 5.9. Transdermal Patches
    • 5.9.1. Global Drug Device Combination Products Market, by Transdermal Patches, by Region, 2020-2034 (USD Billion)
  • 5.10. Antimicrobial Catheters
    • 5.10.1. Global Drug Device Combination Products Market, by Antimicrobial Catheters, by Region, 2020-2034 (USD Billion)
  • 5.11. Other
    • 5.11.1. Global Drug Device Combination Products Market, by Other, by Region, 2020-2034 (USD Billion)

6. Global Drug Device Combination Products Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • 6.3. Cardiovascular Disorder
    • 6.3.1. Global Drug Device Combination Products Market, by Cardiovascular Disorder, by Region, 2020-2034 (USD Billion)
  • 6.4. Diabetes
    • 6.4.1. Global Drug Device Combination Products Market, by Diabetes, by Region, 2020-2034 (USD Billion)
  • 6.5. Respiratory Problems
    • 6.5.1. Global Drug Device Combination Products Market, by Respiratory Problems, by Region, 2020-2034 (USD Billion)
  • 6.6. Cancer Treatment
    • 6.6.1. Global Drug Device Combination Products Market, by Cancer Treatment, by Region, 2020-2034 (USD Billion)
  • 6.7. Other
    • 6.7.1. Global Drug Device Combination Products Market, by Other, by Region, 2020-2034 (USD Billion)

7. Global Drug Device Combination Products Market, by End-user

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • 7.3. Hospitals
    • 7.3.1. Global Drug Device Combination Products Market, by Hospitals, by Region, 2020-2034 (USD Billion)
  • 7.4. Ambulatory Surgical Centers
    • 7.4.1. Global Drug Device Combination Products Market, by Ambulatory Surgical Centers, by Region, 2020-2034 (USD Billion)
  • 7.5. Others
    • 7.5.1. Global Drug Device Combination Products Market, by Others, by Region, 2020-2034 (USD Billion)

8. Global Drug Device Combination Products Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Drug Device Combination Products Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 8.3. Drug Device Combination Products Market - North America
    • 8.3.1. North America: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
    • 8.3.2. North America: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
    • 8.3.3. North America: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
    • 8.3.4. Drug Device Combination Products Market - U.S.
      • 8.3.4.1. U.S.: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
      • 8.3.4.2. U.S.: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
      • 8.3.4.3. U.S.: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
    • 8.3.5. Drug Device Combination Products Market - Canada
      • 8.3.5.1. Canada: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
      • 8.3.5.2. Canada: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
      • 8.3.5.3. Canada: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • 8.4. Drug Device Combination Products Market - Europe
    • 8.4.1. Europe: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
    • 8.4.2. Europe: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
    • 8.4.3. Europe: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
    • 8.4.4. Drug Device Combination Products Market - UK
      • 8.4.4.1. UK: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
      • 8.4.4.2. UK: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
      • 8.4.4.3. UK: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
    • 8.4.5. Drug Device Combination Products Market - France
      • 8.4.5.1. France: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
      • 8.4.5.2. France: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
      • 8.4.5.3. France: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
    • 8.4.6. Drug Device Combination Products Market - Germany
      • 8.4.6.1. Germany: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
      • 8.4.6.2. Germany: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
      • 8.4.6.3. Germany: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
    • 8.4.7. Drug Device Combination Products Market - Italy
      • 8.4.7.1. Italy: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
      • 8.4.7.2. Italy: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
      • 8.4.7.3. Italy: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
    • 8.4.8. Drug Device Combination Products Market - Spain
      • 8.4.8.1. Spain: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
      • 8.4.8.2. Spain: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
      • 8.4.8.3. Spain: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
    • 8.4.9. Drug Device Combination Products Market - Netherlands
      • 8.4.9.1. Netherlands: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
      • 8.4.9.2. Netherlands: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
      • 8.4.9.3. Netherlands: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
    • 8.4.10. Drug Device Combination Products Market - Russia
      • 8.4.10.1. Russia: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
      • 8.4.10.2. Russia: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
      • 8.4.10.3. Russia: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
    • 8.4.11. Drug Device Combination Products Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
      • 8.4.11.2. Rest of Europe: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
      • 8.4.11.3. Rest of Europe: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • 8.5. Drug Device Combination Products Market - Asia Pacific
    • 8.5.1. Asia Pacific: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
    • 8.5.2. Asia Pacific: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
    • 8.5.3. Asia Pacific: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
    • 8.5.4. Drug Device Combination Products Market - China
      • 8.5.4.1. China: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
      • 8.5.4.2. China: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
      • 8.5.4.3. China: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
    • 8.5.5. Drug Device Combination Products Market - India
      • 8.5.5.1. India: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
      • 8.5.5.2. India: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
      • 8.5.5.3. India: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
    • 8.5.6. Drug Device Combination Products Market - Malaysia
      • 8.5.6.1. Malaysia: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
      • 8.5.6.2. Malaysia: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
      • 8.5.6.3. Malaysia: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
    • 8.5.7. Drug Device Combination Products Market - Japan
      • 8.5.7.1. Japan: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
      • 8.5.7.2. Japan: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
      • 8.5.7.3. Japan: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
    • 8.5.8. Drug Device Combination Products Market - Indonesia
      • 8.5.8.1. Indonesia: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
      • 8.5.8.2. Indonesia: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
      • 8.5.8.3. Indonesia: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
    • 8.5.9. Drug Device Combination Products Market - South Korea
      • 8.5.9.1. South Korea: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
      • 8.5.9.2. South Korea: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
      • 8.5.9.3. South Korea: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
    • 8.5.10. Drug Device Combination Products Market - Australia
      • 8.5.10.1. Australia: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
      • 8.5.10.2. Australia: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
      • 8.5.10.3. Australia: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
    • 8.5.11. Drug Device Combination Products Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
      • 8.5.11.2. Rest of Asia Pacific: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
      • 8.5.11.3. Rest of Asia Pacific: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • 8.6. Drug Device Combination Products Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
    • 8.6.2. Middle East & Africa: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
    • 8.6.3. Middle East & Africa: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
    • 8.6.4. Drug Device Combination Products Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
      • 8.6.4.2. Saudi Arabia: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
    • 8.6.5. Drug Device Combination Products Market - UAE
      • 8.6.5.1. UAE: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
      • 8.6.5.2. UAE: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
      • 8.6.5.3. UAE: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
    • 8.6.6. Drug Device Combination Products Market - Israel
      • 8.6.6.1. Israel: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
      • 8.6.6.2. Israel: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
      • 8.6.6.3. Israel: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
    • 8.6.7. Drug Device Combination Products Market - South Africa
      • 8.6.7.1. South Africa: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
      • 8.6.7.2. South Africa: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
      • 8.6.7.3. South Africa: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
    • 8.6.8. Drug Device Combination Products Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
      • 8.6.8.2. Rest of Middle East & Africa: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
      • 8.6.8.3. Rest of Middle East & Africa: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • 8.7. Drug Device Combination Products Market - Latin America
    • 8.7.1. Latin America: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
    • 8.7.2. Latin America: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
    • 8.7.3. Latin America: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
    • 8.7.4. Drug Device Combination Products Market - Mexico
      • 8.7.4.1. Mexico: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
      • 8.7.4.2. Mexico: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
      • 8.7.4.3. Mexico: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
    • 8.7.5. Drug Device Combination Products Market - Brazil
      • 8.7.5.1. Brazil: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
      • 8.7.5.2. Brazil: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
      • 8.7.5.3. Brazil: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
    • 8.7.6. Drug Device Combination Products Market - Argentina
      • 8.7.6.1. Argentina: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
      • 8.7.6.2. Argentina: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
      • 8.7.6.3. Argentina: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
    • 8.7.7. Drug Device Combination Products Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
      • 8.7.7.2. Rest of Latin America: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
      • 8.7.7.3. Rest of Latin America: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Abbott
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Becton, Dickinson and Company
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Boston Scientific Corporation
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Medtronic
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Novartis AG
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Sensely, Inc.
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Stryker
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Teleflex Incorporated
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Terumo Medical Corporation
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Viatris Inc.
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Hovione
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development